[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Blend Labs insider notice: proposed sale of 4,000 shares. The Form 144 shows 4,000 shares of Blend Labs, Inc. common stock were acquired 02/20/2025 via a restricted stock lapse as equity compensation and are proposed for sale through Charles Schwab & Co., Inc. with an aggregate market value of $14,031 and an approximate sale date of 09/04/2025 on the NYSE. The filing also lists five insider sales by Winnie Ling in the past three months totaling 24,000 shares for $84,997 in gross proceeds, with individual sale dates and proceeds provided in the notice.

Positive

• Clear Rule 144 disclosure with broker, share counts, and aggregate market value provided
• Acquisition type disclosed as restricted stock lapse and payment as equity compensation

Negative

• Substantial insider sales in past three months: 24,000 shares sold for total gross proceeds of $84,997
• Proposed additional sale of 4,000 shares with market value $14,031

Insights

Securities Analyst

TL;DR: Insider plans to sell recently vested equity; recent routine sales totaled 24,000 shares for ~$84,997.

The filing documents a planned sale of 4,000 shares acquired by restricted stock lapse on 02/20/2025 and lists five prior sales by the same seller in the last three months. The use of a broker (Charles Schwab) and explicit aggregate market value ($14,031) conforms to Rule 144 disclosure requirements. For investors, the key factual elements are the acquisition type (equity compensation), the dates of prior sales, and the reported gross proceeds. This is a disclosure of insider liquidity rather than corporate operational news.

Corporate Governance Expert

TL;DR: Filing provides transparent insider sale details; pattern shows recurring disposals but no additional company actions disclosed.

The Form 144 identifies the person for whose account sales occurred and confirms the seller's representation about material nonpublic information. It documents the nature of acquisition (restricted stock lapse) and ties proposed sale to a brokerage. The past three months' sales by Winnie Ling are itemized with dates and proceeds, enabling governance review of insider trading patterns. The filing itself is procedural and compliant; it does not disclose any company-level governance changes or material corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4000	14031.00	255696747	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2025	Restricted Stock Lapse	BLEND LABS, INC.			4000	02/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/03/2025	8000	28000.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/10/2025	4000	14160.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	07/24/2025	4000	14360.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/07/2025	4000	14477.00
Winnie Ling 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	08/22/2025	4000	14000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Blend Labs (BLND) report?

The Form 144 reports a proposed sale of 4,000 common shares acquired 02/20/2025 and five prior insider sales totaling 24,000 shares in the past three months.

Who is the seller named in the recent Blend Labs Form 144 entries?

The past sales listed in the filing identify Winnie Ling as the seller; the proposed 4,000-share sale is recorded through Charles Schwab & Co., Inc.

What was the aggregate market value and planned sale date for the proposed sale?

The proposed 4,000-share sale has an aggregate market value of $14,031 with an approximate sale date of 09/04/2025 on the NYSE.

How many shares and gross proceeds were reported from recent insider sales?

Five sales in the past three months total 24,000 shares with combined gross proceeds of $84,997.

How were the 4,000 shares being sold originally acquired?

They were acquired on 02/20/2025 through a restricted stock lapse as part of equity compensation.